{"id":"https://openalex.org/W4415730331","doi":"https://doi.org/10.1016/j.vhri.2025.101349","title":"RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023","display_name":"RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4415730331","doi":"https://doi.org/10.1016/j.vhri.2025.101349"},"language":"en","primary_location":{"id":"doi:10.1016/j.vhri.2025.101349","doi":"https://doi.org/10.1016/j.vhri.2025.101349","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2025.101349","pdf_url":"https://www.valuehealthregionalissues.com/article/S2212-1099(25)00275-4/pdf","source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","medline"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.valuehealthregionalissues.com/article/S2212-1099(25)00275-4/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102111144","display_name":"Ryutaro Suzuki","orcid":"https://orcid.org/0009-0009-2758-8573","observed_orcids":["https://orcid.org/0009-0009-2758-8573"]},"institutions":[{"id":"https://openalex.org/I64189623","display_name":"Kitasato University","ror":"https://ror.org/00f2txz25","country_code":"JP","type":"education","lineage":["https://openalex.org/I64189623"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryutaro Suzuki","raw_affiliation_strings":["Department of Psychiatry, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan","institution_ids":["https://openalex.org/I64189623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079893286","display_name":"Ryosuke Kumazawa","orcid":"https://orcid.org/0000-0002-8694-6803","observed_orcids":["https://orcid.org/0000-0002-8694-6803"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryosuke Kumazawa","raw_affiliation_strings":["Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan","institution_ids":["https://openalex.org/I23172683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033728193","display_name":"Manabu Akazawa","orcid":"https://orcid.org/0000-0002-4112-6035","observed_orcids":["https://orcid.org/0000-0002-4112-6035"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Manabu Akazawa","raw_affiliation_strings":["Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan","institution_ids":["https://openalex.org/I23172683"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017649309","display_name":"Ken Inada","orcid":"https://orcid.org/0000-0002-3073-4588","observed_orcids":["https://orcid.org/0000-0002-3073-4588"]},"institutions":[{"id":"https://openalex.org/I64189623","display_name":"Kitasato University","ror":"https://ror.org/00f2txz25","country_code":"JP","type":"education","lineage":["https://openalex.org/I64189623"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ken INADA","raw_affiliation_strings":["Department of Psychiatry, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan","institution_ids":["https://openalex.org/I64189623"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2400,"currency":"USD","value_usd":2400},"apc_paid":{"value":2400,"currency":"USD","value_usd":2400},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"49","issue":null,"first_page":"101349","last_page":"101349"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9279999732971191},{"id":"https://openalex.org/keywords/adhd-medication","display_name":"ADHD medication","score":0.9539999961853027},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.8159999847412109},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9620000123977661},{"id":"https://openalex.org/keywords/lisdexamfetamine","display_name":"lisdexamfetamine","score":1.0},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/guanfacine","display_name":"guanfacine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.753600001335144},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.7353000044822693},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4293000102043152},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.2827000021934509},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2354000061750412},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.21310000121593475},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.17710000276565552},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.17059999704360962},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.1655000001192093}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.vhri.2025.101349","doi":"https://doi.org/10.1016/j.vhri.2025.101349","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2025.101349","pdf_url":"https://www.valuehealthregionalissues.com/article/S2212-1099(25)00275-4/pdf","source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","medline"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.vhri.2025.101349","doi":"https://doi.org/10.1016/j.vhri.2025.101349","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2025.101349","pdf_url":"https://www.valuehealthregionalissues.com/article/S2212-1099(25)00275-4/pdf","source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","medline"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415730331.pdf","grobid_xml":"https://content.openalex.org/works/W4415730331.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"To":[0],"investigate":[1],"prescription":[2],"patterns":[3],"for":[4],"attention-deficit/hyperactivity":[5],"disorder":[6],"(ADHD)":[7],"medications":[8],"in":[9],"Japan":[10],"following":[11],"the":[12],"market":[13],"availability":[14],"of":[15],"methylphenidate,":[16],"lisdexamfetamine,":[17],"atomoxetine,":[18],"and":[19],"guanfacine.":[20]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-31T00:00:00"}